These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3142159)

  • 1. [Intensified aggressivity of dominant male mice after the intraventricular administration of 6-hydroxydopamine].
    Serova LI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(3):513-8. PubMed ID: 3142159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraventricular 6-hydroxydopamine lowers isolation-induced fighting behavior in male mice.
    Crawley JN; Contrera JF
    Pharmacol Biochem Behav; 1976 Apr; 4(4):381-4. PubMed ID: 945581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 6-hydroxydopamine on ethanol narcosis in mice.
    Sierralta F; Acevedo X; Ehrmantraut M; Muñoz C
    Acta Physiol Pharmacol Latinoam; 1989; 39(3):307-14. PubMed ID: 2576766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Zoosocial behavior and the endocrine function of the gonads of male mice after destruction of the endings of the noradrenergic neurons in the brain].
    Serova LI; Naumenko EV
    Fiziol Zh SSSR Im I M Sechenova; 1987 Jul; 73(7):876-82. PubMed ID: 3117596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins.
    Eaker EY; Bixler GB; Dunn AJ; Moreshead WV; Mathias JR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):438-42. PubMed ID: 3126292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitated intermale aggression in the mouse after 6-hydroxydopamine administration.
    Pöschlová N; Masek K; Krsiak M
    Neuropharmacology; 1976 Jul; 15(7):403-7. PubMed ID: 988500
    [No Abstract]   [Full Text] [Related]  

  • 10. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of 6-hydroxydopamine on the behavior of rats with differing resistance to stress exposure].
    Gromova EA; Semenova TP; Gasanov GG; Ismaĭlova KhIu; Fast AE; Nesterova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(2):301-9. PubMed ID: 2166392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitated aggression in the rat following 6-hydroxydopamine administration.
    Eichelman BS; Thoa NB; Ng KY
    Physiol Behav; 1972 Jan; 8(1):1-3. PubMed ID: 4677199
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of catecholamines and acetylcholine in the regulation of animal behaviour.
    Herman ZS
    Acta Physiol Pol; 1980; 31 Suppl 20():57-68. PubMed ID: 7190761
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary-adrenal activity and depletion of brain catecholamines after central administration of 6-hydroxydopamine.
    Kaplanski J; Smelik PG
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):263-71. PubMed ID: 4699470
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of intravenously administered 6-hydroxydopamine on the content of monoamines in the median eminence and neurointermediate lobe of the rat.
    Sheward WJ; Watts AG; Fink G; Smith GC
    Neurosci Lett; 1985 Apr; 55(2):141-4. PubMed ID: 2582316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A; Samanin R
    Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.